Ohio Life Insurance - Save up to 70% Off
See what plans you qualify for in just a few minutes
How Life Insurance Underwriters View Hepatitis B and C
Modern underwriting for hepatitis has changed dramatically. Insurers no longer treat a positive hep B or hep C history as an automatic decline. Instead, they focus on three questions: Is the virus active or cured? What do your current liver labs show? Is there any structural liver damage like fibrosis or cirrhosis?
Every application boils down to a combination of viral status, liver function test results, and imaging or biopsy findings. The stronger those look, the closer you get to standard rates.
The four hepatitis profiles underwriters recognize
| Profile | Typical outcome |
|---|---|
| Vaccinated hep B (immune, never infected) | Standard/Preferred, treated as no risk |
| Inactive hep B carrier, normal labs | Standard to mild table rating |
| Active chronic hepatitis (B or C) | Table 2-8, postponement, or decline |
| Cured hep C with SVR, no fibrosis | Standard, sometimes Preferred |
| Cirrhosis (F4) from hepatitis | Usually declined at traditional carriers |
Ohio Life Insurance - Save up to 70% Off
See what plans you qualify for in just a few minutes
Hepatitis C: The Cure Changed Everything
Direct-acting antivirals (DAAs) like Mavyret, Epclusa, and Harvoni cure roughly 95% of hep C patients within 8 to 12 weeks of treatment. Once a patient achieves sustained virologic response (SVR), defined as undetectable HCV RNA at least 12 weeks after finishing treatment, insurers view them very differently from an actively infected applicant.
Waiting periods after a hep C cure
Most carriers want to see 6 to 12 months of documented SVR before offering their best rate classes. Applicants with 1 to 2 years of stable post-treatment labs and no residual fibrosis can often qualify for Standard or even Preferred pricing at carriers like Prudential, John Hancock, and Banner Life.
Active vs. cured hep C at a glance
Hepatitis B: Carrier State vs. Active Infection
Hepatitis B underwriting hinges on whether the infection is inactive (carrier state) or actively replicating. Chronic HBV lasts more than six months, and about 90% of infected adults clear the virus, but those who don't are watched closely by underwriters.
The hep B carrier state
An "inactive carrier" is HBsAg positive but has low or undetectable HBV DNA, normal ALT/AST, and no liver damage on imaging. This is the best possible profile short of a resolved infection. Many carriers will offer Standard or a modest table rating (Table 2-4) if you can document 12 months of stable labs.
Active chronic hepatitis B
If you have detectable HBV DNA and elevated liver enzymes, expect a tougher outcome. Table ratings of 4 through 8 are common, and some carriers will postpone the application until viral load is suppressed with antivirals like Tenofovir or Entecavir. Applicants with well-controlled disease on stable therapy can still get approved, but the file is reviewed more carefully.
Vaccinated hep B applicants
If you were vaccinated against hepatitis B and never contracted the virus, you are treated exactly like any other healthy applicant. Immune status shows up on labs as anti-HBs positive with negative HBsAg. There is zero underwriting penalty, and this is the outcome you want documented before applying. This applies to most healthcare workers, first responders, and anyone vaccinated as an infant since the CDC's universal recommendation in 1991.
How Liver Function Tests and Fibrosis Stage Affect Approval
Underwriters review ALT, AST, GGT, alkaline phosphatase, bilirubin, albumin, and platelet count on every hepatitis application. Persistently elevated enzymes suggest ongoing inflammation, which pushes ratings up. Normal or near-normal LFTs (within 1.5x the upper limit of normal) support the best outcomes.
The fibrosis grid
METAVIR fibrosis staging, usually measured with FibroScan or FIB-4, is often more important than viral load itself:
| Fibrosis Stage | Description | Typical Underwriting Outcome |
|---|---|---|
| F0-F1 | No or mild fibrosis | Standard to Preferred possible |
| F2 | Moderate fibrosis | Table 2-4 |
| F3 | Advanced fibrosis (pre-cirrhotic) | Table 4-8 |
| F4 | Cirrhosis | Usually declined |
Cirrhosis and Its Impact on Eligibility
Cirrhosis (F4 fibrosis) is where traditional underwriting typically ends. Even when hep C has been cured, structural liver damage creates ongoing risk of hepatocellular carcinoma and decompensation, which persists after viral cure.
- Compensated cirrhosis (no varices, no encephalopathy, normal albumin/bilirubin) can occasionally be underwritten at Table 4 to Table 8 by specialty carriers, but most standard insurers decline.
- Decompensated cirrhosis (Child-Pugh B or C) is essentially uninsurable through traditional underwriting. Guaranteed issue whole life is the practical option.
If you have cirrhosis, working with a broker who specializes in pre-existing condition applications can help you avoid unnecessary declines that end up in the MIB database.
Best Life Insurance Companies for Hepatitis Applicants in 2026
No single carrier is best for every hepatitis profile. The trick is matching your specific status (carrier, active, cured, cirrhotic) to insurers with lenient guidelines for that profile.
Carrier shortlist by hepatitis profile
- Cured hep C, SVR achieved: Prudential, John Hancock, Banner Life/Legal & General
- Hep B inactive carrier: John Hancock, Protective, Pacific Life
- Active hep B on treatment: Lincoln Financial, Mutual of Omaha
- Mild-to-moderate fibrosis: Mutual of Omaha, Banner Life, Protective
- Compensated cirrhosis: Very limited; specialty broker required
- Declined or uninsurable: AIG/Corebridge, Gerber Life, Mutual of Omaha guaranteed issue
Similar underwriting patterns apply to other chronic viral conditions. Applicants managing HIV alongside hepatitis should expect additional scrutiny but still have real options in 2026.
Guaranteed Issue Alternatives If You Are Declined
Guaranteed issue whole life asks no medical questions and cannot deny you based on hepatitis status. The trade-offs are steep: coverage caps of $5,000 to $25,000, higher per-dollar premiums, and a 2- to 3-year graded death benefit where natural-cause claims typically pay back premiums plus interest instead of the full face amount.
| Product Type | Face Amount | Underwriting | Best For |
|---|---|---|---|
| Traditional term | $100K-$10M | Full medical | SVR cured, hep B carrier |
| Simplified issue | $50K-$500K | Questions only | Mild fibrosis, controlled disease |
| Guaranteed issue whole life | $5K-$25K | None | Cirrhosis, active disease, prior declines |
AIG/Corebridge and Gerber Life both offer no-medical-question guaranteed issue coverage typically available to ages 50-80. If you are younger and have been declined, simplified issue policies from carriers like Sagicor and companies that skip the exam can offer larger face amounts with just a health questionnaire.
Frequently Asked Questions
Can you get life insurance with hepatitis C after being cured with direct-acting antivirals?
Yes, and often at Standard or better rates. Once you achieve SVR (undetectable HCV RNA 12+ weeks post-treatment) and can document 6 to 12 months of stability, carriers like Prudential and John Hancock will underwrite you similarly to a healthy applicant. Applicants with 1 to 2 years of stable SVR and no fibrosis frequently qualify for Preferred rate classes.
How does life insurance treat a hepatitis B carrier with normal liver enzymes?
Inactive hep B carriers with 12 months of normal ALT/AST, undetectable or low HBV DNA, and no fibrosis on imaging can often qualify for Standard rates. Some carriers add a mild table rating (Table 2-4) as a precaution, but decline is rare when the file shows no liver damage. Documentation from your hepatologist significantly strengthens the application.
Do you have to disclose hepatitis on a life insurance application?
Yes, always. Hepatitis diagnoses show up in prescription databases (Milliman IntelliScript), EHR records, and MIB files, so underwriters will find it regardless. Non-disclosure during the two-year contestability period gives the insurer grounds to deny a death claim entirely, which is the worst possible outcome for your beneficiaries.
What life insurance can I get if I have cirrhosis from hepatitis?
Cirrhosis is declined at almost every traditionally underwritten carrier, including for compensated cases. Your best path is guaranteed issue whole life from AIG, Gerber Life, or Mutual of Omaha, with face amounts of $5,000 to $25,000 and a 2-year graded benefit. Some specialty brokers can occasionally place compensated cirrhosis at Table 6-8, but expect very high premiums.
Are people vaccinated against hepatitis B rated differently?
No. Vaccinated applicants who never contracted the virus are treated as standard healthy risks and pay no premium surcharge. Immune status shows on serology as anti-HBs positive and HBsAg negative. If you were vaccinated in childhood or as a healthcare worker, there is nothing on your record that would trigger a rating.